Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases

INTRODUCTION: Bone marrow derived cellular therapies are an emerging approach to promoting therapeutic angiogenesis in ischemic cardiovascular disease. However, the percentage of regenerative cells in bone marrow mononuclear cells (BMMNCs) is small, and large amounts of BMMNCs are required. Ixmyeloc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ledford, Kelly J, Murphy, Nikki, Zeigler, Frank, Bartel, Ronnda L, Tubo, Ross
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413547/
https://www.ncbi.nlm.nih.gov/pubmed/25889271
http://dx.doi.org/10.1186/s13287-015-0007-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413547/
https://www.ncbi.nlm.nih.gov/pubmed/25889271
http://dx.doi.org/10.1186/s13287-015-0007-3

Ejemplares similares